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Abstract
Background: There is a lack of agreement among fertility specialists with regard to
the routine use of mock embryo transfer (MET) before each in vitro fertilization (IVF)
treatment cycle. While MET may be beneficial with previous difficult embryo transfer
cases, its routine use before first IVF cycle has not been evaluated.
Objective: To find out the effect of MET before the first IVF cycle on clinical pregnancy
rate.
Materials and Methods: This is a single-centre randomized controlled trial with a
balanced randomization (1:1), carried out between November 2015 and October 2017,
with 200 subjects at Homerton university hospital, London, randomized into either
MET or control. The primary outcome was clinical pregnancy rate (detection of heart
activity on the ultrasound scan), the secondary outcome measures were live birth rate,
miscarriage and multiple pregnancy rates, difficult ETs, rate of blood or mucus on the
catheter tip.
Results: No significant differences were observed in the baseline or cycle
characteristics between the two groups. The clinical pregnancy rate was similar
between the MET and control groups based on both intension to treat and per protocol
analyses (p = 0.98, p = 0.92, respectively). Additionally, no significant difference was
seen in the live birth rate in both groups on intension to treat and per protocol analyses
(p = 0.67, p = 0.47), respectively.
Conclusion: Our study concludes that MET prior to first IVF cycle may not improve the
success rate in young women without risk factors for a difficult embryo transfer.
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1. Introduction
The advent of assisted reproductive technology
(ART) has given some hope to several women and
couples who previously had no hope of achieving
pregnancies. ART involves several sequences of
procedures. The embryo transfer (ET) procedure is
a vitally important part of the in vitro fertilisation/
intracytoplasmic sperm injection (IVF/ICSI) process.
Multiple factors like quality of embryos, technique
of transfer, receptivity of endometrium can affect
pregnancy outcome after ET (1). The importance
of correct ET technique for successful IVF cannot
be overemphasized as ET is viewed as the most
crucial and critical step in an assisted conception
treatment cycle. Poor ET technique may be
responsible for up to 30% failure rates in ART (2-
4).
There are several suggestions for overcoming
the mechanical problems of ET technique. These
include proper evaluation of the length and the
direction of the uterine cavity to discover any
unanticipated difficulty in entering the uterine
cavity while performing real ET and also to
choose the most suitable catheter for ET (2).
MET was therefore introduced to minimize a
potential mechanical problem encountered
at ET and to improve the pregnancy rate
(5). MET and ultrasound can be used for
evaluation of uterine cavity. The details of
uterocervical angulation and length may make
ET easy. Studies have shown that ultrasound
guided transfers are better in term of clinical
pregnancy outcomes and ongoing pregnancy
rates compared to clinical touch method (6-
8).
There is a trend to perform this procedure
as a routine for all-comers before the first cycle
of IVF treatment even in the absence of any
risk factors. In addition recently MET has been
very popular in private practice, evidence to
offer such treatments are questionable. There
is therefore an obvious need for a study
evaluating MET in women with low risk factors
for difficult transfer in order to determine whether
it should be adopted as a routine procedure.
We performed a randomized controlled trial to
examine the effectiveness of MET for women
undergoing their first cycle of IVF without any
risk factors suggestive of potentially difficult
ET.
2. Materials and Methods
This is a single-centre randomized controlled
trial with a balanced randomization (1:1), conducted
at a tertiary referral unit in London, UK. The
inclusion criteria of the study were couples with
primary subfertility undergoing their first cycle
of IVF or ICSI, where the female partner was
aged between 23 and 42 completed years,
with a body mass index (BMI) of 18-35, in a
fresh or frozen cycle. The exclusion criteria, on
the other hand, were known uterine anomaly,
previous cervical surgery, cone biopsy, large loop
excision of the transformation zone, previous ET or
hysteroscopy.
Eligible couples were randomiszed to the
intervention of MET with a soft ET catheter
(Wallace) on an average three months before the
actual ET. The findings of MET or non-intervention
were noted on a study proforma to guide the
actual ET. A soft Wallace catheter was used to
sound the uterus without ultrasound guidance
and to measure utero-cervical length (UCL) and in
addition to note the position of the uterus, external
cervical os appearance, easy or difficult procedure.
The uterine cavity length at MET was recorded
as the distance in centimeters from the external
cervical os to the uterine fundus. Both groups had
1 or 2 top-quality embryos transferred either on
day 5 blastocyst or day 3 cells stage.
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All subjects were followed until the end of
the time horizon. Those who opted out from the
trial and didn’t proceed to an actual ET were
noted. All randomized couples were analyzed in
their allocated group as per ITT analysis as well
as analysis per protocol/ ET. While the primary
outcome was clinical pregnancy rate (detection
of heart activity on the ultrasound scan), the
secondary outcome measures were live birth rate,
miscarriage and multiple pregnancy rates, difficult
ETs, rate of blood or mucus on the catheter tip.
Computer randomized numbers were utilized.
Consecutively numbered, individual opaque
envelops were used for allocation. Eligible
subjects were given verbal information as well
as written information about the trial. At the next
appointment the consent formwas signed followed
by opening of the consecutively numbered sealed
envelope by the research coordinator to assign
the patient for the intervention. The majority
of the women in the study underwent a frozen
embryo replacement cycle. These women had
mock transfer immediately after oocyte retrieval
and actual ET was carried out in three months
following the oocyte retrieval as this was the
waiting time for frozen embryo replacement cycle.
Subjects who underwent fresh ET had mock
transfer about three months before the start of
the fresh IVF cycle. After the intervention mock,
ET findings were noted in the proforma which
was filed in the notes with an aim to review
during actual embryos transfer process. Women
who had a difficult MET were offered either a
senior consultant review or hysteroscopy and
cervical dilatation before the actual ET. The
doctor (AB) performing MET was also trained in
performing ETs as per standard unit policy. Due
to the intervention involved in the trial, blinding
was not possible. This was unlikely to affect
the outcome of the trial, as the outcome was
objective.
2.1. Ethical consideration
The study has been approved by the local ethics
committee at Homerton university hospital (REC
reference 13/LO/1834). All the participants gave
their informed consent.
2.2. Statistical analysis
Based on the ITT and per protocol principles,
statistical comparisons were carried out using two
sample t tests and epidemiological aspects to
calculate relative risk with its significance value
and confidence intervals. Also, we used more
informative summary statistics where appropriate
with the Statistical Program for Social Sciences
(SPSS, Inc., Version 21.0, Chicago, IL, USA). A two-
sided P-value, 0.05 was considered as statistically
significant.
3. Results
Between November 2015 and October 2017,
230 couples undergoing their first IVF/ICSI cycle
were approached. Of these, 200 were randomized
to either mock ET or control groups (Figure 1). There
were no differences between the two groups in
terms of baseline characteristics (Table I). Shapiro-
Wilk Normality test was used to check normality.
3.1. Mock ET group
Of the 106 subjects randomized to the Mock
ET group, 9 did not reach the stage of ET, and
two never started their treatment cycle. Besides,
one patient was lost to follow-up, while six subjects
had stimulation for the IVF/ICSI cycle but didn’t
undergo ET either because of personal reasons, a
spontaneous conception, or there was no embryo
available due to failure of fertilization. MET findings
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showed the average UCL was 7.4 in our study
population. Twenty-three of the ninety-six (23.95%)
subjects had a pin-point cervix at the time of MET
and one had fibrosis at the external cervical os. A
total of 97 of the 106 subjects in the mock group
had ET. Of these, 93 (95.87 %) subjects had an
easy mock transfer with soft ET catheter (Wallace),
while 3 met difficulty in the MET with the soft
catheter, where in MET was performed easily with
routine ET catheter using a stylet. The actual ET
for all of the three cases experienced no difficulty
in the transfer. However, only one patient (1.03%)
had a difficult mock transfer even with the use
of a stylet and she underwent hysteroscopy and
cervical dilatation before the actual ET. All theMETs
were performed by registrars except one that was
performed by a consultant. Accordingly, 60 out of
the 97 (61.85 %) actual ETs were performed by
registrars and 37 (38.14%) by the consultants. All
ETs were done with the Wallace Sure Pro catheter
as a standard practice in our unit. Only one patient
(1.03%) had difficulty with actual ET in spite of easy
MET as per the operators notes but there was no
evidence of bleeding or mucus at the tip of the
catheter. All the rest of the subjects had an easy
ET as per the documentation in the notes.
In total, 25 out of 97 (25.77%) subjects had
retroversion of the uterus, 3 (3%) had mid-position
or axial uterus, and 68 (70.1%) had an ante-verted
uterus. In one subject, it was not possible to find
out the position due to difficulty in MET. Four
out of ninety-seven (4.12%) subjects’ ET findings
revealed blood at the tip of catheter, and in
seven (7.21%), cases there was mucus at the tip
of the catheter. In addition, 85 of the 97 (87.62%)
MET group subjects had either one or two top-
quality embryos transferred. The average number
of embryos transferred in the MET group was 1.26.
In the MET group, 71 of the 103 (68.93%) subjects
had single and 26 (25.24%) had double ETs. None
underwent triple ET in theMET group; 88% of these
subjects had day 5 embryos transferred. Of the 97
subjects, 47 (48.45%) had a positive HCG test and
31 (31.95%) had a live birth; 10 of the 47 (21.27%)
subjects had miscarriage, 4 (8.15%) biochemical, 1
(2.12%) ectopic, and 1 (2.12%) had termination of
pregnancy for congenital abnormality.
3.2. Control group
Of the 94 subjects randomized to the control
group, 7 did not reach the stage of ET. One patient
didn’t start the treatment cycle and one was lost
to follow-up. Five subjects had stimulation for the
IVF/ICSI cycle but didn’t undergo ET either due to
personal reasons, a spontaneous conception, or
absence of embryo due to failure of fertilization. A
total of 87 subjects in the control group had actual
ET. All ETs were done with the Wallace Sure Pro
catheter as a standard practice in our unit (Figure
1). None of these subjects had any difficulty during
the ET. Four out of the 87 (4.59%) patient’s ET
findings revealed blood at the tip of catheter and
in 6 (6.89%) cases there was mucus at the tip of the
catheter.
Out of the 87 subjects (87.35%), 76 in the control
group had either one or two top-quality embryos
transferred. The average number of embryos
transferred in the control group was 1.32. While
60 out of 92 (65.21%) had single ET in the control
group, 26 (31.52%) had double ET. Only one patient
(1.08%) underwent triple ET due to her age and
average quality of the embryo. In the control group,
85% subjects had day 5 embryos transferred.
Of the 87, 51 (58.62%) ETs were performed by
registrars and 36 (41.37%) by the consultants. A total
of 38 (43.67%) subjects had a positive HCG, while
25 (28.73%) had a live birth and 13 (14.94%) had
miscarriage. As presented in Table II, no significant
difference were seen between the two groups in
terms of protocol used, IVF/ICSI procedure, fresh
or frozen ET, quality and number of embryos
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transferred,. Although the number of oocytes was
different between the groups (p = 0.03), we do not
believe this could have influenced the outcomes
of our study question (Table II). The statistical test
used is two sample t test.
3.3. Primary outcomes
There was no significant difference in the clinical
pregnancy rates between the MET and control
groups based on both ITT [40.56% (43/106) vs
40.42% (38/94); RR 1.0035 (95% CI = 0.7167 -
1.4051), p = 0.98] and per protocol [44.32% (43/97)
vs 43.67% (38/87); RR 1.0149 (95% CI = 0.7321-
1.4069), p = 0.92] analyses (Table III).
3.4. Secondary outcomes
There was no significant difference in the
live birth rate between the MET and control
groups based on ITT [29.24% (31/106) vs 26.59%
(25/94); RR 1.0996 (95% CI = 0.7027-1.7207),
p = 0.67] and per protocol [31.95% (31/97) vs
28.73% (25/87); RR 1.1122 (95% CI = 0.7161-
1.7273), p = 0.47] analyses. In addition, there
were no significant differences in the miscarriage
nor multiple pregnancy rates based on both the
ITT and per protocol analyses (Table III). The
statistical test used is two sample t test. Most
importantly in the control group, none of the
subjects had difficult ET, while in the MET group
only one patient had difficult ET. The MET group
identified four difficult transfers, of which only one
required intervention of hysteroscopy and cervical
dilatation. Both the groups had similar incidence
for the finding of catheter tip bleeding and/or
mucus which can be a sign of difficult ET. The
doctors performing actual ET were qualified as
per units standard practice measures. There was
no statistically significant difference in the two
different operators performing the actual transfers
in both the groups.
Table I. Baseline Characteristics of the Mock and control group
Variables Mock (mean) Control (mean) P-value Min Max Range
Age (yr) 32.00 33.00 0.06 24.00 42.00 18.00
Duration of subfertility (months) 39.89 39.84 0.99 12.00 120.00 108.00
BMI (kg/m2) 24.703 24.690 0.97 18.40 35.00 16.60
AFC (n) 26.87 24.99 0.32 5.00 75.00 70.00
FSH (IU/L) 5.208 5.510 0.17 1.00 11.90 10.90
AMH (pmol/l) 35.4000 30.9400 0.63 3.20 121.55 118.35
Shapiro-Wilk Normality test and Student t test, BMI: Body mass index, AMH: Anti-Müllerian hormone, FSH: Follicle-stimulating
hormone; AFC: Antral follicle count
Table II. Cycle characteristics of the mock and control groups
MOCK (n = 103) Control (n = 92) P-value Relative risk (95% CI)
Protocol
Long agonist 4/103 (3.88) 01/92 (1.09) 0.25 3.5728 (0.4066-31.3931)
Antagonist 99/103 (96.12) 91/92 (98.91) 0.20 0.9717 (0.9296-1.0158
Insemination
IVF 47/103 (45.63) 37/92 (40.22) 0.44 1.1346 (0.8187-1.5725)
ICSI 32/103 (31.07) 37/92 (40.22) 0.18 0.7725 (0.5280-1.1302)
Split 24/103 (23.30) 18/92 (19.57) 0.52 1.1909 ( 0.6922-2.0490)
Fresh 5//97 (4.85) 09/87 (10.34) 0.16 0.4693 (0.1633-1.3481)
Frozen 92/97 (89.32) 78/87 (89.66) 0.94 0.9963 (0.9035-1.0986)
Number of oocytes obtained* 18 (5-64) 15 (3-41) 0.03
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Table II. Continued.
Quality of embryos
Top 85/97 (91.75) 76/87 (87.36) 0.95 1.0031 (0.8991-1.1192)
Average 12/97 (12.37) 11/87 (12.64) 0.95 0.9784 (0.4552-2.1032)
Number of transferred embryos
0 6/103 (5.83) 05/92 (5.43) 0.90 1.0718 (0.3384-3.3954)
1 71/103 (68.93) 60/92 (65.22) 0.58 1.0570 (0.8674-1.2880)
2 26/103 (25.24) 26/92 (28.26) 0.63 0.8932 (0.5609-1.4223)
3 0/103 (0 ) 01/92 (1.09) 0.45 0.2981 (0.0123-7.2284)
Actual transfer
Easy 96/97 (98.97) 87/87 (100) 0.31 0.9897 (0.9698-1.0100)
Difficult 01/97 (1.03) 0/87 (0) 0.54 2.6939 (0.1112-65.2795)
Catheter tip bleeding 04/97 (4.12) 04/87 (4.60) 0.87 0.8969 (0.2313-3.4784)
Catheter tip mucus 07/97 (7.22) 06/87 (6.90) 0.93 1.0464 (0.3657-2.9942)
Consultant 37/97 (38.14) 36/87 (41.38) 0.65 0.9218 (0.6457-1.3161)
Registrar 60/97 (61.86) 51/87 (58.62) 0.65 1.0552 (0.8335-1.3358)
Data presented as n (%). P-value refer to Chi-squared test; when appropriate, P-value < 0.05 was considered as significant. *
independent t test, IVF: In vitro fertilisation, ICSI: Intracytoplasmic sperm injection
Table III. Pregnancy outcomes mock and control groups (ITT and per protocol analyses)
Analysis by ITT (n = 200) MOCK (n = 106) Control (n = 94) Relative risk (95% CI) P-value
Clinical pregnancy rate 43/106 (40.56) 38/94 (40.42) 1.0035 (0.7167-1.4051) 0.98
Live birth rate 31/106 (29.24) 25/94 (26.59) 1.0996 (0.7027-1.7207) 0.67
Miscarriage rate 10/47 (21.27) 13/38 (34.21) 0.6219 (0.3073-1.2585) 0.18
Multiple pregnancy rate 3/43 (6.97) 3/38 (7.89) 0.8837 (0.1895-4.1209) 0.87
Analysis per protocol /ET (n = 184) Mock (n = 97) Control (n = 87 ) Relative risk (95% CI) P-value
Clinical pregnancy rate 43/97 (44.32) 38/87 (43.67) 1.0149 (0.7321-1.4069) 0.92
Live birth rate 31/97 (31.95) 25/87 (28.73) 1.1122 (0.7161-1.7273) 0.47
Miscarriage rate 10/47 (21.27) 13/38 (34.21) 0.6219 (0.3073-1.2585) 0.18
Multiple pregnancy rate 3/43 (6.97) 3/38 (7.89) 0.8837 (0.1895-4.1209) 0.87
Data presented as n (%), ITT: Intension to treat, Chi-squared test, P-value < 0.05 was considered as significant. Clinical
pregnancy: Detection of heart activity on the ultrasound scan; Live birth rate: The percentage of all cycles that lead to live
birth (more than 20 wk)
Eligible couples approached (n = 230) 
Randomized (n = 200) 
Mock Group (n = 106) Control Group (n = 94) 
Did not receive intervention (n = 2) 
1 Patient lost to follow up 
1 Patient did not start treatment 
30 patients declined to participate 
Analysis per protocol 
Did not receive intervention (n = 3) 
1 Patient lost to follow up 
2 Patient did not start treatment 
Completed follow-up (n =103) Completed follow-up (n = 92) 
Embryo transfer (n = 87) 
No embryo transfer (n = 5) 
Embryo transfer (n = 97) 
No embryo transfer (n = 6) 
Analysis intention to treat 
Analyzed (n = 94) Analyzed (n = 106) 
Figure 1. Consort flowchart.
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4. Discussion
From the present study, MET before the actual
ET did not result in significant improvement in
the clinical pregnancy rates or live birth rates
among women undergoing their first IVF/ICSI
cycle with no evidence of potential risk factors
anticipating difficult ET. It has been suggested
that one of the reasons for performing a Mock
ET is to aid assessment of uterine size and
position. However, the uterine findings at a
mock ET are not always a definite predictor
of uterine length and position at the time of
the real ET. The uterine length and position
is known to be variable due to the effect of
hormones on the uterine muscle and on the size
of the ovaries. To minimize this variation in the
uterine length, the majority of ETs were done at
the time of oocyte retrieval where there is an
influence of hormones and actual transfer was
also performed in the hormone medicated frozen
cycle (9-11).
Similarly, in our study, MET was performed at
the time of oocyte retrieval, where the hormonal
effect would be present and actual ET was
also performed in a hormone-medicated frozen
ET cycle. Uterine depth is very much different
with pre-cycle blind MET compared to ultrasound
guided measurement at the ET. Hence it is not
the best predictor for assessing final ET depth
(10). Although in our study the UCL was measured
during MET, the actual transfer was performed
as per unit’s policy of transferring the embryo
in the lower 2/3 rd of the uterine cavity under
trans-abdominal ultrasound guidance. The uterine
position at a mock ET cannot also always be a
true predictor of the position of the uterus at
the time of a real ET as uterine position can
vary (9). Henne (2004) conducted a study to
determine the consistency in the uterine position
between mock and real ET. Henne and coworker
reviewed the 996 consecutive ET cycles (585
subjects); 74% of subjects had an anteverted (AV)
uterus and 26% had a retroverted (RV) uterus
at MET. In our study, the results very much
resemble the aforementioned study. Although
the primary outcome seems obvious, a larger
sample would be needed to confirm live birth
outcome.
There are variable opinions from different
practitioners about the exact timings of Mock
ET. It has variously been performed either
prior to initiation of IVF/ICSI treatment cycle or
immediately before the real ET (5, 12-14). In our
study, we deliberately removed the positive as
well as negative effect of endometrial injury during
MET at the time of oocyte retrieval by deferring
actual ET for three months or more in a frozen
cycle as majority of our subjects were hyper-
responders (Table II) and underwent a freeze all
cycle as per the units protocol to minimize risk of
ovarian hyper stimulation. Difficult ET and its effect
on clinical pregnancy outcome is not very clear. In
the literature, some studies have shown that there
is a correlation between difficult ET and reduced
pregnancy rate (15, 16). On the other hand some
studies have suggested that difficult or repeated
ET does not adversely affect the outcome of IVF
(17). Mansour and colleagues in a randomized
trial showed that lower pregnancy rate in the
controls is due to the very low pregnancy rate
(4%) in difficult ET cases. Dummy ET can avoid
unexpected difficult and failed ET (5). This is in
contrast to our study where the pregnancy rates
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are not statistically different between the two
groups. The major difference in these two studies
is the use of ultrasound guidance during ET which
was not used in the earlier studies making the
success rates variable. Although choosing the
type of catheter may be a benefit of MET, in
our study we had three cases where we used
a different type of catheter for MET, as not all
catheters are suitable for every patient. MET is
very helpful in difficult subjects and for selecting
the most suitable catheter. Sometimes it is difficult
to achieve proper straight alignment between the
cervix and uterus due to acutely tilted utero-
cervical angle. Proper evaluation of these cases
can be done just before loading the embryos
or in pre-treatment MET procedures. Full bladder
can also help in straightening the utero-cervical
angle.
A study by Tomas and co-workers concluded
that difficult ET markedly reduces the pregnancy
rate. Need for cervical dilatation or catheter
change or blood on the catheter indicates difficult
ET. Easy or intermediate transfers resulted in a 1.7-
fold higher pregnancy rate than difficult transfers
(18). In our study, 24 women had a pin-point
cervix at the time of MET but none of them
had any difficulty either during METs or actual
ETs. This suggests that pin-point cervix can be
a common finding (23.29% in our study) in the
nulliparous woman and should not be a sole
indication for MET. Several studies have shown
that blood and/or mucus on the tip of catheter
may indicate difficult transfer and can affect the
pregnancy outcome (1, 19-21). In this study, we did
not find any difference between the occurrence
of blood or mucus at the tip of catheter in
both the groups. Currently, training in medicine
is competency based. In ART, performance of
mock ET is likely to have a positive impact on
training. Mock ET can be a practice procedure
to improve on competence of trainees before
they are deemed competent to perform the actual
procedure. In a survey by Wittenberger and
colleague recommended that hands-on approach
should be included for ET training in reproductive
endocrinology and infertility fellowship training
(22).
5. Conclusion
Our study concludes that MET prior to first
IVF/ICSI cycle may not improve the success
rates in young women without risk factors
for a difficult ET. MET doesn’t improve the
pregnancy rate and difficult ETs are not very
common. In addition, MET procedure will require
additional resources including catheter costs,
staff availability, appointments, and extra visits
for the subjects. MET should be reserved for
subjects with risk factors for potential difficult
ET.
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